 Superior protective effect low-calcium magnesium-free potassium cardioplegic solution ischemic myocardium Clinical study comparison Thomas Hospital solution protective effect low-calcium magnesium-free potassium cardioplegic solution ischemic myocardium adult patients undergoing heart operations Postreperfusion recovery cardiac function electrical activity patients low-calcium magnesium-free potassium cardioplegic solution group received Thomas Hospital solution calcium magnesium group II significant differences groups age sex body weight New York Heart Association functional class Aortic occlusion time minutes minutes myocardial temperature elective global ischemia degrees degrees versus degrees degrees total volume cardioplegic solution ml/kg versus ml/kg similar groups reperfusion electrical defibrillation cases group cases group II bradyarrhythmias prevalent group II Serum creatine kinase MB activity minutes reperfusion IU/L versus IU/L dose dopamine dobutamine early phase reperfusion micrograms/kg/min versus micrograms/kg/min group II Postischemic ventricular function percent recovery left ventricular end-systolic pressure-volume relationship patients aortic replacement group Serum level calcium magnesium ions group low-calcium magnesium-free potassium cardioplegic solution excellent protection ischemic heart whereas Thomas Hospital solution calcium magnesium poor functional electrical recovery heart early reperfusion period results levels extracellular calcium magnesium reperfusion